CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Jan. 01, 2022	Dec. 26, 2020
Cash flows from operating activities
Net (loss) income	$ 48,810	$ (68,307)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Depreciation and amortization	112,796	124,881
Amortization of debt issuance costs	5,046	3,962
Stock-based compensation	34,214	31,104
Deferred income taxes	(115,660)	(15,373)
Provision for excess and obsolete inventories	8,160	12,767
Restructuring and other related charges	33,977	49,477
Cash payments for restructuring charges	(27,515)	(28,794)
Other operating activities	(1,526)	(6,000)
Changes in assets and liabilities
Accounts receivable, net	(8,569)	(71,439)
Inventory, net	(24,699)	(39,941)
Current and other assets	(9,129)	(15,246)
Accounts payable	9,170	62,454
Accrued liabilities	(45,502)	47,529
Income taxes	(19,625)	(15,925)
Net cash (used in) provided by operating activities	(52)	71,149
Cash flows from investing activities
Proceeds from sales of short-term investments	264	667
Purchases of short-term investments	(760)	(394)
Capital expenditures	(20,682)	(16,753)
Proceeds from sale of property, plant, and equipment	0	1,900
Other investing activities	(4,000)	0
Net cash used in investing activities	(25,178)	(14,580)
Cash flows from financing activities
Employees' tax withheld and paid for restricted stock and restricted stock units	(12,154)	(3,193)
Proceeds from issuances under stock-based compensation plans	5,841	5,731
Proceeds from revolving line of credit	0	50,000
Repayments of revolving line of credit	0	(50,000)
Repayments of long-term debt	(480,689)	(46,980)
Net cash used in financing activities	(487,002)	(44,442)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(1,536)	4,059
Net (decrease) increase in cash and cash equivalents and restricted cash	(513,768)	16,186
Cash and cash equivalents and restricted cash at beginning of period	696,468	213,879
Cash and cash equivalents and restricted cash at end of period	182,700	230,065
Cash and cash equivalents	182,700
Restricted cash	0
Total cash and cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows	$ 182,700	$ 230,065